These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15539124)

  • 1. Increased plasma homocysteine concentrations accelerate cardiac allograft vasculopathy.
    Kutschka I; Pethig K; Harringer W; Haverich A; Strüber M;
    J Heart Lung Transplant; 2004 Nov; 23(11):1260-5. PubMed ID: 15539124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing plasma homocysteine during follow-up in heart transplant recipients: effects of folate and renal function.
    Potena L; Grigioni F; Magnani G; Sorbello S; Sassi S; Marinucci L; Conti R; Carinci V; Leone O; Arpesella G; Coccheri S; Magelli C; Branzi A
    Ital Heart J; 2000 May; 1(5):344-8. PubMed ID: 10832810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians.
    Pitla S; Nagalla B
    Ann Nutr Metab; 2009; 54(1):1-6. PubMed ID: 19194102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine neither lowers plasma homocysteine concentrations nor improves brachial artery endothelial function in cardiac transplant recipients.
    Miner SE; Cole DE; Evrovski J; Forrest Q; Hutchison SJ; Holmes K; Ross HJ
    Can J Cardiol; 2002 May; 18(5):503-7. PubMed ID: 12032576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of homocysteine concentration in coronary heart disease patients and comparison of two determination methods.
    Doncheva N; Penkov A; Velcheva A; Boev M; Popov B; Niagolov Y
    Ann Nutr Metab; 2007; 51(1):82-7. PubMed ID: 17356259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.
    Winkelmayer WC; Kramar R; Curhan GC; Chandraker A; Endler G; Födinger M; Hörl WH; Sunder-Plassmann G
    J Am Soc Nephrol; 2005 Jan; 16(1):255-60. PubMed ID: 15563562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Homocysteine as a risk factor for ischemic heart disease].
    Nakamura Y; Yoshizawa H
    Rinsho Byori; 2002 Aug; 50(8):807-14. PubMed ID: 12373818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
    Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
    J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes.
    Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Patsourakos NG; Adamopoulou EN; Beldekos DJ; Melidonis AI; Handanis SM; Manolis AJ; Hatzisavvas JJ; Argyrakis SK
    Int J Cardiol; 2008 Mar; 124(3):312-8. PubMed ID: 17433477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum total homocysteine concentration does not predict outcome in renal transplant recipients.
    Dimény E; Hultberg B; Wahlberg J; Fellström B; Arnadottir M
    Clin Transplant; 1998 Dec; 12(6):563-8. PubMed ID: 9850451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
    Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
    J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
    Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
    J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation.
    Sánchez Lázaro IJ; Almenar Bonet L; Moro López J; Sánchez Lacuesta E; Martínez-Dolz L; Agüero Ramón-Llín J; Andrés Lalaguna L; Cano Pérez O; Ortiz Martínez V; Buendía Fuentes F; Salvador Sanz A
    Transplant Proc; 2008 Nov; 40(9):3056-7. PubMed ID: 19010192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of fasting total serum homocysteine levels in liver transplant recipients.
    Akoglu B; Wondra K; Caspary WF; Faust D
    Exp Clin Transplant; 2006 Jun; 4(1):462-6. PubMed ID: 16827644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation.
    Cook RC; Tupper JK; Parker S; Kingsbury K; Frohlich JJ; Abel JG; Gao M; Ignaszewski AP
    J Heart Lung Transplant; 1999 May; 18(5):420-4. PubMed ID: 10363685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.